Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study

Author:

Ferrières Jean12ORCID,Bruckert Eric3ORCID,Farnier Michel4ORCID,Krempf Michel5ORCID,Mourad Jean-Jacques6ORCID,Roux Baptiste7,Schiele François8ORCID

Affiliation:

1. Department of Cardiology, Toulouse Rangueil University Hospital, Toulouse University School of Medicine, Toulouse, France

2. INSERM UMR 1295, Toulouse Paul Sabatier University, Toulouse, France

3. Department of Endocrinology Metabolism & Cardiovascular Prevention, Pitié Salpêtrière Hospital, E3M Institute & IHU Cardiometabolic (ICAN), Paris, France

4. Team PEC2, EA 7460, University of Bourgogne Franche-Comté, Dijon, France

5. Department of Endocrinology, Bretéché Clinic, Nantes, France

6. Department of Internal Medicine, Hôpital Franco-Britannique, Levallois, France

7. Clinical Research Department, FAST4, Nîmes, France

8. Department of Cardiology, CHU Besançon, University of Franche-Comté, Besançon, EA 3920, France

Abstract

Aim:This online interactive survey investigated lipid-lowering approaches of French cardiologists in high- and very high-cardiovascular risk patients with hypercholesterolemia.Materials & methods:Physicians assessed three hypothetical patients at three clinic visits, and selected the patients’ cardiovascular risk category, target low-density lipoprotein cholesterol (LDL-C) and treatment.Results:A total of 162 physicians completed 480 risk assessments; 58% of assessments correctly categorized the hypothetical patients. Most physicians chose the correct LDL-C target for one of the very high-risk patients, but higher-than-recommended targets were selected for the other very high-risk patient and the high-risk patient. Statins were the most commonly chosen treatment.Conclusion:French cardiologists often underestimate cardiovascular risk in patients with hypercholesterolemia, select a higher-than-recommended LDL-C target and prescribe less intensive treatment than that recommended by guidelines.

Funder

Servier

Publisher

Becaris Publishing Limited

Subject

Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3